44 Economists Answer Questionnaire on the Pre-Market Approval of Drugs and Devices
AbstractIn the January 2010 issue of this journal, we called, by name, 305 health economists to answer, without anonymity, an online interactive questionnaire about the pre-market approval of drugs and devices, and about the existence of a market-failure rationale for the policy. Of those called, 44 individuals participated. Here we summarize their answers to the closed-end questions and provide full transcripts of all the virtual conversations. We do not respond to or evaluate the responses. The 44 respondents come from 12 countries. Most of the respondents hold academic positions, but others are in government, industry, the non-profit health sector, and private research/consultancy. Link to this report's appendix which contains the 44 transcripts
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Econ Journal Watch in its journal Econ Journal Watch.
Volume (Year): 7 (2010)
Issue (Month): 2 (May)
You can help add them by filling out this form.
reading list or among the top items on IDEAS.Access and download statisticsgeneral information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Jason Briggeman) The email address of this maintainer does not seem to be valid anymore. Please ask Jason Briggeman to update the entry or send us the correct address.
If references are entirely missing, you can add them using this form.